Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Charles River Laboratories VP Christopher Perkins On Building Preclinical Facilities In China: An Interview With PharmAsia News (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

Wilmington, Mass.-based contract research organization Charles River Laboratories offers drug discovery and development services to global pharmaceutical and biotechnology companies, government agencies, and leading academic institutions. Senior VP Christopher Perkins recently spoke with PharmAsia News about the company's operations in China and the landscape there for preclinical services.

You may also be interested in...



Charles River Set To Launch First Global CRO Preclinical Testing Center In China

BEIJING - Charles River Laboratories, one of the world's leading contract research organizations, is set to open a new preclinical testing facility this week in the rapidly expanding Chinese market, according to Senior VP Christopher Perkins

Charles River Set To Launch First Global CRO Preclinical Testing Center In China

BEIJING - Charles River Laboratories, one of the world's leading contract research organizations, is set to open a new preclinical testing facility this week in the rapidly expanding Chinese market, according to Senior VP Christopher Perkins

Covance, WuXi Abandon Plans To Create Joint Drug Testing Facility In China

BEIJING - Just three months after unveiling plans to create a joint venture facility for preclinical drug testing services on China's east coast, the Shanghai-headquartered WuXi PharmaTech and and Princeton, N.J.-based Covance have called off the deal

Related Content

UsernamePublicRestriction

Register

WI965023

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel